|
|
 |
|
Viewing report
|
|
|
|
Drug Delivery - Snapshots and Highlights
Frost & Sullivan, April 2007, Pages: 46
This Frost & Sullivan research service titled Drug Delivery: Snapshots and Highlights provides an insight into the pharmaceutical and biotech sectors and their strategies for new and innovative methods of drug delivery. In this research service, Frost & Sullivan's expert analysts examine the areas of implant delivery, oral modified release, and nanobiotechnology. Also discussed are business strategy trends currently important in drug delivery relative to business development, licensing, and lifecycle management.
Patent Expiries and Generic Competition Increase Focus on Product Lifecycle Management
Drug delivery is an important facet of pharmaceutical product development. Changing a drug’s delivery method can help improve the product’s therapeutic benefits and revenue potential. The prolonged research and clinical evaluation process for drugs reduces the patent life for pharmaceuticals. This pressure compels pharmaceuticals developers to use novel product lifecycle management strategies to maximize revenue and extend IP. Altering a drug’s delivery technology has proven to be an effective strategy.
Continued technology evolution is also vital for drug development and future pharmacotherapy. 'Business strategies have increasingly begun to include aspects of drug delivery technologies,' notes the analyst of this research service. 'Drug delivery companies can potentially enable pharmaceutical companies to revive late stage products by using new drug delivery platforms.'
Drug Delivery Sector Continue to Focus on Innovative Methods
'Recent technological advances in drug delivery methods are opening up new avenues for manufacturers,' says the analyst. 'Marketing a drug with multiple available routes of administration in particular can increase product success.' Within the realm of oral delivery, modified release (extended release/controlled release) is expected to bring benefits to companies from both product performance and business standpoints. Another promising technology, nanobiotechnology, is an exciting application for all forms of drug delivery and could have a substantial impact in the way drugs are being manufactured. Implantable drug delivery also has the potential to meet the distinctive therapeutic needs of some patients. Meanwhile, with the predominant indications of pain medications and hormone treatment, transdermal drug delivery has entered a new era with the active and traditional passive patch deliveries.
Overall, pharmaceutical companies now have an increasing amount of choices while determining the most successful route of delivery for their products. With increasing competition and R&D costs, partnerships between pharmaceutical and drug delivery companies are expected to continue to strengthen in the future, as companies seek to deal with issues such as lifecycle management and new product innovation.
Customers who bought this item also bought
Drug Delivery - Snapshots and Highlights
Drug Delivery Systems in Cancer Therapeutics
Application Lifecycle Management - A Technology Evaluation and Comparison Report
Gene Silencing With RNA Interference: A New Generation of Pharmaceuticals
Snapshots US Pasta 2007
Chinese Pharmaceutical Industry: Strategies, Trends and Opportunities
Snapshots UK Oral Hygiene 2007
Peptides 2006 - New Applications in Discovery, Manufacturing, and Therapeutics
|
|
|
|
